Terms ending in 2039
Every in-force patent on Alector LLC's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,472,874 | ANTI-MS4A4A Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 11,976,119 | Anti-SIRPa Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 12,258,410 | Anti-SIRPa Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 12,215,149 | ANTI-MS4A6A Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 11,396,546 | Anti-Sortilin Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 11,779,642 | Anti-SIRP-Alpha Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.